UroGen Pharma URGN
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 23.42 | -105 | -26 | -13.68 | 200 | |
| 2025Q3 | 19.95 | -115 | -33 | -16.94 | 185 | |
| 2025Q2 | 13.70 | -93 | -50 | -21.89 | 209 | |
| 2025Q1 | 11.06 | -46 | -44 | -16.44 | 248 | |
| 2024Q4 | 10.65 | -9 | -38 | -12.77 | 286 | |
| 2024Q3 | 12.70 | 26 | -84.81 | -24 | -8.11 | 302 |
| 2024Q2 | 16.78 | 30 | -33 | -13.85 | 282 | |
| 2024Q1 | 15.00 | -40 | -32 | -17.04 | 201 | |
| 2023Q4 | 15.00 | -65 | -26 | -13.99 | 178 | |
| 2023Q3 | 14.01 | -42 | -22 | -15.14 | 194 | |
| 2023Q2 | 10.35 | -138 | -24 | -23.17 | 95 | |
| 2023Q1 | 9.24 | -117 | -30 | -24.31 | 113 | |
| 2022Q4 | 8.87 | -89 | -29 | -21.86 | 136 | |
| 2022Q3 | 8.32 | -63 | -26 | -18.81 | 128 | |
| 2022Q2 | 8.19 | -41 | -27 | -17.12 | 146 | |
| 2022Q1 | 8.71 | -17 | -28 | -19.89 | 166 | |
| 2021Q4 | 9.51 | 8 | -142.44 | -28 | -22.37 | 120 |
| 2021Q3 | 16.82 | 32 | -68.81 | -30 | -20.95 | 135 |
| 2021Q2 | 15.27 | 56 | -39.50 | -26 | -20.88 | 154 |
| 2021Q1 | 19.48 | 76 | -30.01 | -26 | -23.64 | 97 |